EvolVeritas Biotechnology Ltd.

Private

BudapestHealthcare & Life Scienceshttps://evolveritas.com/

Last Round

Grant

Mar 22, 2022

Total Funding Raised

$943,700

Company Overview

EvolVeritas Biotechnology Ltd. is a biotechnology company that develops drug compounds through the development of specific protein molecules for therapeutic areas such as ischemic reperfusion injury, thrombosis, and COVID-19.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

directed protein evolutionphage display platformdrug candidate developmentstructure-driven protein engineeringischemia-reperfusion injuryMASP-2 inhibitorbiologics discoverytherapeutic proteinpreclinical biotechdrug licensingviral infection therapeuticsresearch tool ligandsbiotech spinoffrecombinant protein productionIgA nephropathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvolVeritas Biotechnology Ltd. Comps

Public and private peers based on sector, stage, and business model.

EvolVeritas Biotechnology Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EvolVeritas Biotechnology Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 22, 2022

View all Funding Rounds

EvolVeritas Biotechnology Ltd. Investors

Notable investors and investment history

EvolVeritas Biotechnology Ltd. investors
Investor	Rounds
PBG FMC Venture Capital Fund Management	Seed
National Research, Development and Innovation Office	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 22, 2022
$922K grant from National Research, Development and Innovation Office.

View all signals

EvolVeritas Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

EvolVeritas Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EvolVeritas Biotechnology Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBudapest

Year Founded2011

Last FundingMar 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.